Nitric oxide protects against ischemic acute renal failure through the suppression of renal endothelin-1 overproduction

Journal of Cardiovascular Pharmacology

Volumn 44, Issue SUPPL. 1, 2004, Pages

  Kurata, Hayato ^a   Takaoka, Masanori ^a   Kubo, Yasuhiro ^a   Katayama, Tomoaki ^a   Tsutsui, Hidenobu ^a   Takayama, Junji ^a   Matsumura, Yasuo ^a  

^a OSAKA MEDICAL COLLEGE   (Japan)

Author keywords

Acute renal failure; Endothelin 1; Nitric oxide; Renal function

Indexed keywords

4 ETHYL 2 HYDROXYIMINO 5 NITRO 3 HEXENAMIDE; ENDOTHELIN 1; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE INHIBITOR;

ACUTE KIDNEY FAILURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CONFERENCE PAPER; DISEASE EXACERBATION; HISTOPATHOLOGY; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; KIDNEY INJURY; KIDNEY ISCHEMIA; KIDNEY VEIN; MALE; NEPHRECTOMY; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION INJURY; VEIN OCCLUSION;

ANIMALS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; ENZYME INHIBITORS; INJECTIONS, INTRAVENOUS; KIDNEY; KIDNEY FAILURE, ACUTE; KIDNEY FUNCTION TESTS; MALE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE DONORS; NITRIC OXIDE SYNTHASE; NITRO COMPOUNDS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY; TIME FACTORS;

EID: 11144290158     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000166314.38258.a8     Document Type: Conference Paper

References (12)

1. Boulanger C, Lüscher TF. Release of endothelin from the porcine aorta: Inhibition by endothelium-derived nitric oxide. J Clin Invest. 1991;85: 587-590.
2. Mitsutomi N, Akashi C, Odagiri J, et al. Effects of endogenous and exogenous nitric oxide on endothelin-1 production in cultured vascular endothelial cells. Eur J Pharmacol. 1999;364:65-73.
3. Schiffrin EL. Endothelin: potential role in hypertension and vascular hypertrophy. Hypertension. 1995;25:1135-1143.
4. Firth JD, Ratcliffe PJ. Organ distribution of the three rat endothelin messenger RNAs and the effects of ischemia on renal gene expression. J Clin Invest. 1992;90:1023-1031.
5. B receptor, is protective against ischemic acute renal failure in rats. Jpn J Pharmacol 2000;82:307-316.
6. Wilhelm SM, Simonson MS, Robinson AV, et al. Endothelin upregulation and localization following renal ischemia and reperfusion. Kidney Int. 1999;55:1011-1018.
7. Kita Y, Hirasawa Y, Maeda K, et al. Spontaneous nitric oxide release accounts for the potent pharmacological actions of FK409. Eur J Pharmacol. 1994;257:123-130.
8. Matsumura Y, Nishiura M, Deguchi S, et al. Protective effect of FK409, a spontaneous nitric oxide releaser, on ischemic acute renal failure in rats. J Pharmacol Exp Ther. 1998;287:1084-1091.
9. Chintala MS, Chiu PJ, Vemulapalli S, et al. Inhibition of endothelial derived relaxing factor (EDRF) aggravates ischemic acute renal failure in anesthetized rats. Naunyn-Schmiedebergs Arch Pharmacol. 1993;348:305-310.
10. Matsumura Y, Kuro T, Kobayashi Y, et al. Protective effect of SM-19712, a novel and potent endothelin converting enzyme inhibitor, on ischemic acute renal failure in rats. Jpn J Pharmacol. 2000;84:16-34.
11. Gellai M, Jugus M, Fletcher T, et al. Nonpeptide endothelin receptor antagonist V: prevention and reversal of acute renal failure in the rat by SB 209670. J Pharmacol Exp Ther. 1995;275:200-206.
12. Ohkita M, Takaoka M, Sugii M, et al. The role of nuclear factor-κB in the regulation of endothelin-1 production by nitric oxide. Eur J Pharmacol. 2003;472:159-164.